As of 2026-05-26, the EV/EBITDA ratio of Sun Pharma Advanced Research Co Ltd (SPARC.NS) is 5.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SPARC.NS's latest enterprise value is 81,191.41 mil INR. SPARC.NS's TTM EBITDA according to its financial statements is 16,097.10 mil INR. Dividing these 2 quantities gives us the above SPARC.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.3x - 14.7x | 13.3x |
| Forward P/E multiples | 13.2x - 15.1x | 13.6x |
| Fair Price | 494.70 - 25,277.12 | 11,646.59 |
| Upside | 112.3% - 10749.0% | 4898.8% |
| Date | EV/EBITDA |
| 2026-05-25 | 5.04 |
| 2026-05-22 | 4.64 |
| 2026-05-21 | 3.98 |
| 2026-05-20 | 4.04 |
| 2026-05-19 | 3.98 |
| 2026-05-18 | 3.61 |
| 2026-05-15 | 3.65 |
| 2026-05-14 | 3.80 |
| 2026-05-13 | 3.75 |
| 2026-05-12 | 3.69 |
| 2026-05-11 | 3.75 |
| 2026-05-08 | 3.84 |
| 2026-05-07 | 3.72 |
| 2026-05-06 | 3.51 |
| 2026-05-05 | 3.17 |
| 2026-05-04 | 3.17 |
| 2026-04-30 | 3.22 |
| 2026-04-29 | 3.35 |
| 2026-04-28 | 3.31 |
| 2026-04-27 | 3.30 |
| 2026-04-24 | 3.14 |
| 2026-04-23 | 3.24 |
| 2026-04-22 | 3.24 |
| 2026-04-21 | 3.26 |
| 2026-04-20 | 3.26 |
| 2026-04-17 | 3.31 |
| 2026-04-16 | 3.42 |
| 2026-04-15 | 3.38 |
| 2026-04-13 | 3.21 |
| 2026-04-10 | 3.33 |
| 2026-04-09 | 3.28 |
| 2026-04-08 | 3.11 |
| 2026-04-07 | 2.89 |
| 2026-04-06 | 2.83 |
| 2026-04-02 | 2.84 |
| 2026-04-01 | 2.77 |
| 2026-03-30 | 2.67 |
| 2026-03-27 | 2.77 |
| 2026-03-25 | 2.98 |
| 2026-03-24 | 2.60 |
| 2026-03-23 | 2.54 |
| 2026-03-20 | 2.66 |
| 2026-03-19 | 2.68 |
| 2026-03-18 | 2.75 |
| 2026-03-17 | 2.67 |
| 2026-03-16 | 2.65 |
| 2026-03-13 | 2.71 |
| 2026-03-12 | 2.81 |
| 2026-03-11 | 2.86 |
| 2026-03-10 | 2.87 |